LSI Industries LYTS Crushes Q1 2026 Estimates EPS 029 Tops Views OpenAIs Sam Altman Takes the Stand in Trial Over Elon Musks Claims of Charity Misappropriation Baidu BIDU Q4 2025 Earnings Surprise EPS 1062 Up Significant Equus EQS Stalls at 138 Breakout or Breakdown 20260518 Tech Rally Drives Major Indexes Higher Amid Mixed Sector Performance Why Waldencast WALDW Just Dropped 1489 What to Watch 20260520 SEC Proposes Streamlined Reporting and Capital Raising Rules for Newly Public Companies Market Volatility Continues as ITC Nykaa and IndusInd Bank Lead Q4 Results Focus Lenskart Profit Drops Dr Reddys Launches Diabetes Drug GD Holdings Acquires 16 St Regis Chicago Condos from Sony in 21M Transaction Fed Dissenters Explain Opposition to Policy Statement Cite Concerns Over Rate Cut Signal IPO Market Primer Key Steps and Considerations for Companies Going Public ColgatePalmolive India Shifts Focus to Premium Oral Care and Digital Execution for Growth Healthcare and Tech Lift SP 500 to New High Communications Slips Lenovo Shares Surge Over 15 on Record Earnings AI Revenue Nearly Doubles MarketAxess MKTX Q1 2026 Earnings EPS Beats Estimates Amid Mixed Market Conditions The Oncology Institute Inc TOI Q1 2026 Earnings Narrowing Losses Drive Substantial EPS Beat FGBIP Q1 2026 Earnings Earnings Beat Expectations with 96 Surprise Omada Health Q1 2026 Earnings Narrowerthanexpected Loss Drives Positive Stock Reaction EXPE Q1 2026 Earnings Strong EPS Beat Amid Revenue Uncertainty China Tightens CrossBorder Stock Trading Rules Five Key Details NPCE Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Surprise Gap Inc Q1 2026 Earnings Earnings Miss Estimates Amid Strategic Transition BGC Group Inc BGC Q1 2026 Earnings Slight EPS Miss Amid Modest Share Gains White Mountains Insurance Group Q2 2025 Earnings EPS Misses Estimates Stock Edges Higher Great Elm Group Q1 2026 Earnings Massive EPS Miss Sends Stock Lower ESI Q1 2026 Earnings EPS Beat Drives Positive Market Reaction BBOT Q1 2026 Earnings NarrowerthanExpected Loss Lifts Sentiment as Stock Declines PHGE Q4 2025 Earnings Severe EPS Miss as BiomX Continues Clinical Development